Computer simulations suggest that prostate enlargement due to benign prostatic hyperplasia mechanically impedes prostate cancer growth

Abstract

Prostate cancer and benign prostatic hyperplasia are common genitourinary diseases in aging men. Both pathologies may coexist and share numerous similarities, which have suggested several connections or some interplay between them. However, solid evidence confirming their existence is lacking. Recent studies on extensive series of prostatectomy specimens have shown that tumors originating in larger prostates present favorable pathological features. Hence, large prostates may exert a protective effect against prostate cancer. In this work, we propose a mechanical explanation for this phenomenon. The mechanical stress fields that originate as tumors enlarge have been shown to slow down their dynamics. Benign prostatic hyperplasia contributes to these mechanical stress fields, hence further restraining prostate cancer growth. We derived a tissuescale, patient-specific mechanically coupled mathematical model to qualitatively investigate the mechanical interaction of prostate cancer and benign prostatic hyperplasia. This model was calibrated by studying the deformation caused by each disease independently. Our simulations show that a history of benign prostatic hyperplasia creates mechanical stress fields in the prostate that impede prostatic tumor growth and limit its invasiveness. The technology presented herein may assist physicians in the clinical management of benign prostate hyperplasia and prostate cancer by predicting pathological outcomes on a tissue-scale, patient-specific basis.prostate cancer | benign prostatic hyperplasia | mathematical oncology | patient-specific | isogeometric analysis

Integrating Quantitative Assays with Biologically Based Mathematical Modeling for Predictive Oncology

“…ODE models are limited to temporal dynamics, but this enables their use in a wide range of cellular and tissue-scale settings that can leverage multiple types of time-resolved data ( Benzekry et al., 2014 ; Jarrett et al., 2019 ; Johnson et al, 2020 ; Lorenzo et al., 2019b ; Mendoza-Juez et al., 2012 ; Morken et al., 2014 ). PDE models further include spatial dynamics and constitute the standard approach for clinical, tissue-scale applications, which usually rely on longitudinal in vivo imaging data ( Hormuth et al., 2020 ; Jarrett et al., 2018 ; Lorenzo et al., 2019a ; Mang et al., 2020 ; Rockne et al., 2015 ; Wong et al., 2017 ). Additionally, hybrid models combine a discrete and continuous formulation, which may require multiscale multimodal data ( Metzcar et al., 2019 ; Phillips et al., 2020 ; Vilanova et al., 2017 ; Wang et al., 2015 ).…”

Digital twinning of Cellular Capsule Technology: emerging outcomes from the perspective of porous media mechanics

“…This is particularly true for biochemical and genetic approaches which have been validated in patient cohorts, such as e.g. for the prediction of surgical volume for breast and prostate locations [7], [8], and for the prediction of the chemical agent diffusion for pancreatic cancer [9].…”

Discovering pathways in benign prostate hyperplasia: A functional genomics pilot study

“…Benign prostate hyperplasia (BPH), also known as prostate gland enlargement, is a genitourinary condition that is most prevalent in aging males, usually starting at 50-61 years of age ( 1 ), and causing lower urinary tract symptoms (LUTS), such as urine flow blockage as a result of the urethra being compressed by the enlarged gland. Other potential complications may include bladder, urinary tract or kidney problems ( 2 ).…”